[Press release – not published yet] Moderna says its COVID vaccine produced a strong antibody response for kids 6 to 11.
26 Oct, 2021 | 02:06h | UTCPress release: Moderna Announces Positive Top Line Data from Phase 2/3 Study of COVID-19 Vaccine in Children 6 to 11 Years of Age
Commentary: Moderna says new data supports its COVID vaccine for kids 6 to 11 – NPR